NYSE:SYK - アナリストの将来予測と過去の財務データ ( )USD Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
12/31/2026	25,818	5,004	4,597	5,544	20
12/31/2025	24,019	4,489	4,198	5,077	26
12/31/2024	22,300	3,887	3,463	4,230	26
3/31/2024	20,963	3,361	2,858	3,470	N/A
12/31/2023	20,498	3,165	3,136	3,711	N/A
9/30/2023	19,885	2,585	2,568	3,186	N/A
6/30/2023	19,455	2,709	2,417	3,025	N/A
3/31/2023	18,952	2,627	2,267	2,866	N/A
12/31/2022	18,449	2,358	2,036	2,624	N/A
9/30/2022	17,948	2,457	2,015	2,621	N/A
6/30/2022	17,629	2,079	2,067	2,665	N/A
3/31/2022	17,430	2,015	2,453	3,014	N/A
12/31/2021	17,108	1,994	2,738	3,263	N/A
9/30/2021	16,669	1,900	3,016	3,500	N/A
6/30/2021	16,246	2,083	2,973	3,396	N/A
3/31/2021	14,716	1,408	2,712	3,138	N/A
12/31/2020	14,351	1,599	2,790	3,277	N/A
9/30/2020	14,220	1,756	2,254	2,775	N/A
6/30/2020	14,070	1,601	1,960	2,575	N/A
3/31/2020	14,956	2,164	1,798	2,469	N/A
12/31/2019	14,884	2,083	1,542	2,191	N/A
9/30/2019	14,549	3,426	1,898	2,502	N/A
6/30/2019	14,204	3,550	1,910	2,491	N/A
3/31/2019	13,876	3,522	2,053	2,626	N/A
12/31/2018	13,601	3,553	2,038	2,610	N/A
9/30/2018	13,276	1,236	1,639	2,243	N/A
6/30/2018	13,040	1,080	1,098	1,704	N/A
3/31/2018	12,730	1,019	1,125	1,705	N/A
12/31/2017	12,444	1,020	N/A	1,559	N/A
9/30/2017	12,130	1,779	N/A	1,538	N/A
6/30/2017	11,957	1,700	N/A	1,961	N/A
3/31/2017	11,785	1,689	N/A	1,804	N/A
12/31/2016	11,325	1,647	N/A	1,915	N/A
9/30/2016	10,883	1,659	N/A	1,928	N/A
6/30/2016	10,470	1,605	N/A	917	N/A
3/31/2016	10,062	1,617	N/A	781	N/A
12/31/2015	9,946	1,439	N/A	981	N/A
9/30/2015	9,849	1,177	N/A	907	N/A
6/30/2015	9,818	933	N/A	1,940	N/A
3/31/2015	9,749	669	N/A	1,953	N/A
12/31/2014	9,675	515	N/A	1,782	N/A
9/30/2014	9,525	641	N/A	1,775	N/A
6/30/2014	9,287	687	N/A	1,873	N/A
3/31/2014	9,136	772	N/A	1,859	N/A
12/31/2013	9,021	1,006	N/A	1,886	N/A
9/30/2013	8,891	890	N/A	1,810	N/A
6/30/2013	8,792	1,140	N/A	1,757	N/A

アナリストによる今後の成長予測

収入対貯蓄率: SYKの予測収益成長率 (年間10.5% ) は貯蓄率 ( 2.4% ) を上回っています。

収益対市場: SYKの収益 ( 10.5% ) US市場 ( 14.8% ) よりも低い成長が予測されています。

高成長収益: SYKの収益は増加すると予測されていますが、大幅には増加しません。

収益対市場: SYKの収益 ( 7% ) US市場 ( 8.7% ) よりも低い成長が予測されています。

高い収益成長: SYKの収益 ( 7% ) 20%よりも低い成長が予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: SYKの自己資本利益率は、3年後には高くなると予測されています ( 21.9 %)

Stryker 将来の成長

Future 基準チェック /26

主要情報

今後の成長に関する最新情報

Stryker Corporation Provides Earnings Guidance for the Full Year 2024

Stryker Corporation Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Stryker Corporation (NYSE:SYK) Analysts Are Pretty Bullish On The Stock After Recent Results

Stryker Corporation Provides Earnings Guidance for the Year 2024

Stryker Corporation Provides Earnings Guidance for the Full Year 2023

Stryker Corporation Provides Earnings Guidance for the Year 2023

Recent updates

Stryker (NYSE:SYK) Will Pay A Dividend Of $0.80

The Returns At Stryker (NYSE:SYK) Aren't Growing

Stryker Releases Lifepak 35 Monitor/Defibrillator

Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Stryker Corporation (NYSE:SYK) agreed to acquire Artelon, Inc.

Stryker: Margin Gains Should Drive Upside

First European Announces That Surgeries Completed Using Stryker’s Gamma4 Hip Fracture Nailing System

Does Stryker (NYSE:SYK) Have A Healthy Balance Sheet?

VP & CFO recently sold US$3.3m worth of stock

Market Participants Recognise Stryker Corporation's (NYSE:SYK) Earnings

First quarter dividend of US$0.80 announced

Stryker Corporation Provides Earnings Guidance for the Full Year 2024

Stryker Corporation Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

We Ran A Stock Scan For Earnings Growth And Stryker (NYSE:SYK) Passed With Ease

Stryker: A Great Company At An Expensive Price

Stryker Corporation to Report Q1, 2024 Results on Apr 30, 2024

Stryker's (NYSE:SYK) Dividend Will Be $0.80

Stryker Launches Gamma4 Hip Fracture Nailing System in Europe

Estimating The Fair Value Of Stryker Corporation (NYSE:SYK)

Upcoming dividend of US$0.80 per share

Stryker (NYSE:SYK) Hasn't Managed To Accelerate Its Returns

VP & Chief Accounting Officer notifies of intention to sell stock

At US$348, Is Stryker Corporation (NYSE:SYK) Worth Looking At Closely?

Stryker (NYSE:SYK) Has Announced A Dividend Of $0.80

Fourth quarter dividend of US$0.80 announced

New minor risk - Insider selling

Independent Director recently sold US$100m worth of stock

Independent Director notifies of intention to sell stock

Stryker: A Dividend Growth Powerhouse I'd Like To Own

Stryker Announces the Launch of Prophecy Footprint, an Expansion of the Prophecy Surgical Planning System, Offering Comprehensive Surgical Planning Across the Entire Foot

Stryker Corporation (NYSE:SYK) Analysts Are Pretty Bullish On The Stock After Recent Results

Full year 2023 earnings: EPS and revenues exceed analyst expectations

Stryker Corporation Provides Earnings Guidance for the Year 2024

Stryker (NYSE:SYK) Seems To Use Debt Quite Sensibly

VP & CFO exercised options and sold US$8.3m worth of stock

Here's Why We Think Stryker (NYSE:SYK) Might Deserve Your Attention Today

Insufficient new directors

Stryker: Mako Shoulder And Spine Launches Are On The Way

Stryker's (NYSE:SYK) Shareholders Will Receive A Bigger Dividend Than Last Year

Upcoming dividend of US$0.80 per share at 1.0% yield

Stryker Corporation (NYSE:SYK) executed a binding offer to acquire Serf from SAS Menix.

Stryker's (NYSE:SYK) Shareholders Will Receive A Bigger Dividend Than Last Year

Stryker Corporation, Annual General Meeting, May 09, 2024

Stryker Corporation Announces Dr. Srikant Datar Will Retire from Board of Directors

Stryker Corporation Declares Quarterly Dividend, Payable on January 31, 2024

VP & CFO exercised options and sold US$1.6m worth of stock

Why Stryker Is An Awesome Healthcare Compounder

Chairman notifies of intention to sell stock

Is Now An Opportune Moment To Examine Stryker Corporation (NYSE:SYK)?

Stryker Corporation Provides Earnings Guidance for the Full Year 2023

Third quarter 2023 earnings: EPS misses analyst expectations

Investors Could Be Concerned With Stryker's (NYSE:SYK) Returns On Capital

Stryker: Don't Buy This Dividend Champion (Yet)

Stryker to Showcase Q Guidance System with Spine Guidance Software

Estimating The Fair Value Of Stryker Corporation (NYSE:SYK)

Stryker Corporation to Report Q3, 2023 Results on Nov 02, 2023

Is Stryker (NYSE:SYK) A Risky Investment?

Upcoming dividend of US$0.75 per share at 1.0% yield

Stryker Launches PROstep® MIS Lapidus, a New Minimally Invasive Surgical Option for Treating Patients with Bunions

Stryker Corporation Releases Its Next-Generation of Advanced Surgical Cameras

Stryker’S Pangea Systems Receive Food & Drug Administration Clearance

Key Executive recently sold US$1.4m worth of stock

Stryker: Procedure Volume Recovery And Mako's Leading Robotic Technology

Stryker Corporation Provides Earnings Guidance for the Year 2023

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Some Investors May Be Worried About Stryker's (NYSE:SYK) Returns On Capital

Stryker Corporation's (NYSE:SYK) Intrinsic Value Is Potentially 18% Below Its Share Price

Stryker Corporation to Report Q2, 2023 Results on Aug 03, 2023